Cargando…
Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy
Cationic (positively charged) liposomes have been tested in various gene therapy clinical trials for neoplastic and other diseases. They have demonstrated selectivity for tumour vascular endothelial cells raising hopes for both antiangiogenic and antivascular therapies. They are also capable of bein...
Autores principales: | Dass, Crispin R, Choong, Peter FM |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524816/ https://www.ncbi.nlm.nih.gov/pubmed/16792817 http://dx.doi.org/10.1186/1475-2867-6-17 |
Ejemplares similares
-
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
por: Tan, Mei Lin, et al.
Publicado: (2010) -
Enhanced localization of anticancer drug in tumor tissue using polyethylenimine-conjugated cationic liposomes
por: Han, Hee Dong, et al.
Publicado: (2014) -
Tumour associated vasculature-on-a-chip for the evaluation of microbubble-mediated delivery of targeted liposomes
por: Bourn, Matthew D., et al.
Publicado: (2023) -
Liposomal Drug Delivery Systems and Anticancer Drugs
por: Olusanya, Temidayo O. B., et al.
Publicado: (2018) -
Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
por: Mann, Aman P., et al.
Publicado: (2010)